CA Patent

CA3070948A1 — Systems and methods for locating and/or characterizing intragastric devices

Assigned to Obalon Therapeutics Inc · Expires 2019-01-31 · 7y expired

What this patent protects

Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of tracking and locating the same are provided.

USPTO Abstract

Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of tracking and locating the same are provided.

Drugs covered by this patent

Patent Metadata

Patent number
CA3070948A1
Jurisdiction
CA
Classification
—
Expires
2019-01-31
Drug substance claim
No
Drug product claim
No
Assignee
Obalon Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.